Viewing Study NCT00435669


Ignite Creation Date: 2025-12-24 @ 10:48 PM
Ignite Modification Date: 2025-12-25 @ 8:17 PM
Study NCT ID: NCT00435669
Status: COMPLETED
Last Update Posted: 2009-01-22
First Post: 2007-02-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase I Study to Determine Absorption, Distribution, Metabolism, and Elimination of a Single Radiolabeled Dose of Brivanib (BMS-582664)
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module